Investor
News and Information

Investor

Press Releases

Events

Environmental Protection Acceptance Monitoring Report (Revised) for the Completion of Key Pharmaceutical Intermediate Projects CL001, LA-06, etc., of Zhejiang Aoxiang Pharmaceutical Co., Ltd. (Pilot)

Release Date:

2023-12-15

Environmental Protection Acceptance Monitoring Report (Revised) for the Completion of Key Pharmaceutical Intermediate Projects CL001, LA-06, etc., of Zhejiang Aoxiang Pharmaceutical Co., Ltd. (Pilot)

Related News

Uniting Hearts and Pooling Strength to Innovate for a Bright Future — Aoxiang Pharmaceutical Grandly Holds the 2025 Annual Summary and Awards Ceremony and the 2026 Kickoff Meeting

Uniting Hearts and Pooling Strength to Innovate for a Bright Future — Aoxiang Pharmaceutical Grandly Holds the 2025 Annual Summary and Awards Ceremony and the 2026 Kickoff Meeting

2026-02-25

Leading the Peptide Pipeline: Aoxiang Pharmaceutical Deeply Engages in Discussions on Reaction Safety Risk Assessment, Jointly Mapping Out the Industry’s Blueprint

Leading the Peptide Pipeline: Aoxiang Pharmaceutical Deeply Engages in Discussions on Reaction Safety Risk Assessment, Jointly Mapping Out the Industry’s Blueprint

In recent years, Aoxiang Pharmaceutical has, while maintaining its core strengths in active pharmaceutical ingredients, steadfastly implemented a “transformation and upgrading” strategy, prioritizing the research and development of peptide drugs, oligonucleotides, and synthetic biology technologies.

2026-01-13

Share to

Back to List

这里是占位文字

Hotline:

+86-576-85589335

Email:

sales@ausunpharm.com

Company Address:

No.5, Donghai 4th Avenue, Zhejiang Chemical Materials Base Linhai Zone, Taizhou,Zhejiang,China

Zhejiang Ausun Pharmaceutical Co., Ltd. SEO

Business License
Ausun